Dr. Riyi Shi

Co-Founder & Chief Scientific Officer

Dr. Riyi Shi, MD, PhD, Professor, Purdue Neuroscience and Biomedical Engineering • Chief Science Officer • MD, Shanghai Jiao Tong University, School of Medicine. 1984 • PhD, Purdue University, 1994 • Attending Orthopedic Surgeon: Rui-Jin Hospital, Shanghai, China, 1984-1986 • Postdoctoral fellow at University of North Carolina (Chapel Hill), 1994-1996 • Assistant, Associate, then Professor of Neuroscience, Purdue University, 1997-present • Co-Founder and Chief Laboratory Scientist, Andara Life Sciences, Inc. 2005 (acquired by Cyberkinetics Neurotechnology System, Inc. in 2006). • Founding President, Chinese Neurotrauma Scholar Association (US), 2012-2013 • Editorial Advisory Board of Journal of Materials, 2012-present; World Journal of Pharmacology, 2011-present; Neural regeneration Research. • Six US patents issued • Basic Research Advisor: National Multiple Sclerosis Society Indiana State Chapter, 2009-present

David Giddings

Co-Founder & Chief Strategy Officer

David Giddings, • Chief Strategy Officer • 25+ years in life science business arena, with both established global firms and early stage companies • COO/President of Boehringer Mannheim Corp. • Chairman & CEO of Diametrics Medical • CEO of Digilab • Interim CEO Allotrope Pharmaceuticals • Advisor, board member to three Purdue start-ups

Mark Van Fleet

Co-Founder & Chief Business Development Officer

Mark Van Fleet • Chief Business Development Officer • 25+ years in domestic and international business development • Founder and Executive director of Purdue’s Global Business Engagement office • Senior executive with U.S. Chamber of Commerce, business development & international divisions • Entrepreneur (founder of two start-ups)